Sana Biotechnology, Inc. (NASDAQ: SANA)
$3.8850
-0.4150 ( -22.76% ) 21.0M
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.
Market Data
Open
$3.8850
Previous close
$4.3000
Volume
21.0M
Market cap
$923.22M
Day range
$3.7860 - $5.1850
52 week range
$1.5200 - $12.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4/a | Other | 1 | Jul 15, 2024 |
| 4 | Insider transactions | 1 | Jul 08, 2024 |